These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 2709903)

  • 1. [Arterial hypertension, nephrosclerosis and calcium antagonists].
    del Río A
    Med Clin (Barc); 1989 Jan; 92(3):98-101. PubMed ID: 2709903
    [No Abstract]   [Full Text] [Related]  

  • 2. Protecting the kidney in hypertension.
    Weinberg MS; Cottiero RA; Yoburn DC
    R I Med; 1993 May; 76(5):225-8. PubMed ID: 8518496
    [No Abstract]   [Full Text] [Related]  

  • 3. Can calcium channel blockers preserve renal function better than diuretics during antihypertensive treatment?
    Fukuda M; Kimura G
    Arch Intern Med; 2005 Jun; 165(11):1312; author reply 1312-3. PubMed ID: 15956015
    [No Abstract]   [Full Text] [Related]  

  • 4. [Prevention and countermeasures in kidney diseases complicated by hypertension].
    Fujiwara Y; Takama T; Orita Y; Kamada T
    Nihon Rinsho; 1989 Sep; 47(9):2091-6. PubMed ID: 2593282
    [No Abstract]   [Full Text] [Related]  

  • 5. [Calcium antagonists in the differential therapy of arterial hypertension].
    Rosenthal J
    MMW Munch Med Wochenschr; 1982 Nov; 124(47):1047-50. PubMed ID: 6817119
    [No Abstract]   [Full Text] [Related]  

  • 6. [Relationship between essential arterial hypertension and osteoporosis:impact of antihypertensive treatment on extracellular metabolism of calcium].
    Honorato Pérez J; Escolar Jurado M; García Quetglas E
    Rev Clin Esp; 1999 Aug; 199(8):523-9. PubMed ID: 10522434
    [No Abstract]   [Full Text] [Related]  

  • 7. Antihypertensive drugs in renal failure.
    Albert FW
    J Cardiovasc Pharmacol; 1994; 24 Suppl 2():S108-12. PubMed ID: 7898089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The effects of antihypertensive drugs on lipid metabolism. Part I. Diuretics, beta-blockers, calcium antagonists].
    Martynov AI; Ostroumova OD; Mamaev VI; Rybkina TE; Kuznetsov VI; Tikhonova LIa; Smirnova MV
    Klin Med (Mosk); 2001; 79(8):8-12. PubMed ID: 11588795
    [No Abstract]   [Full Text] [Related]  

  • 9. [The role of new dihydropyridine calcium channel blockers in the treatment of hypertension].
    Coca A
    An Med Interna; 2003 Jun; 20(6):279-81. PubMed ID: 12848596
    [No Abstract]   [Full Text] [Related]  

  • 10. Systemic hypertension and antihypertensive agents.
    Maschio G; Marcantoni C; Bernich P
    J Nephrol; 1999; 12 Suppl 2():S100-4. PubMed ID: 10688408
    [No Abstract]   [Full Text] [Related]  

  • 11. The use of calcium-channel blockers in pregnancy.
    Lewis R; Sibai BM
    New Horiz; 1996 Feb; 4(1):115-22. PubMed ID: 8689266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The role of calcium antagonists in the treatment of arterial hypertension].
    Chazova IE
    Ter Arkh; 2001; 73(8):80-3. PubMed ID: 11599278
    [No Abstract]   [Full Text] [Related]  

  • 13. Calcium antagonists for antihypertensive baseline therapy. First International Nitrendipine Symposium. Interlaken, April 13-14, 1984.
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S929-1113. PubMed ID: 6085378
    [No Abstract]   [Full Text] [Related]  

  • 14. [Calcium antagonists in cardiovascular disease. Clinical evidence from morbidity and mortality trials].
    Oparil S; Bakir SE
    Drugs; 2000; 59 Spec No 2():25-37. PubMed ID: 11002856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal and vascular protective effects of cilnidipine in patients with essential hypertension.
    Morimoto S; Yano Y; Maki K; Iwasaka T
    J Hypertens; 2007 Oct; 25(10):2178-83. PubMed ID: 17885563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Calcium antagonist and diurnal blood pressure variation].
    Kabutoya T; Kario K
    Clin Calcium; 2005 Oct; 15(10):1631-41. PubMed ID: 16199908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Do calcium antagonists prevent heart failure in hypertension?].
    Aursnes I
    Tidsskr Nor Laegeforen; 2004 Jan; 124(1):42-3. PubMed ID: 14716392
    [No Abstract]   [Full Text] [Related]  

  • 18. Antihypertensive effect of a new calcium channel blocker, FK 235, in essential hypertension.
    Mizuno K; Hashimoto S; Yabe R; Kunii N; Niimura S; Tani M; Watari H; Fukuchi S
    Res Commun Chem Pathol Pharmacol; 1986 Apr; 52(1):3-15. PubMed ID: 3520729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcium channel blockers and nephroprotection.
    Ungar A; Di Serio C; Lambertucci L; Monami M; Masotti G
    Aging Clin Exp Res; 2005 Aug; 17(4 Suppl):31-9. PubMed ID: 16640171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nephroprotection by antihypertensive agents.
    Schmieder RE
    J Cardiovasc Pharmacol; 1994; 24 Suppl 2():S55-64. PubMed ID: 7898095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.